| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.49 | 0.0005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |